בלסטווין טבע

Country: Israel

Language: Hebrew

Source: Ministry of Health

Active ingredient:

VINBLASTINE SULFATE

Available from:

ABIC MARKETING LTD, ISRAEL

ATC code:

L01CA01

Pharmaceutical form:

תמיסה להזרקה

Composition:

VINBLASTINE SULFATE 1 MG / 1 ML

Administration route:

תוך-ורידי

Prescription type:

אין צורך במרשם

Manufactured by:

PHARMACHEMIE B.V., (TEVA GROUP) ,THE NETHERLANDS

Therapeutic group:

VINBLASTINE

Therapeutic area:

VINBLASTINE

Therapeutic indications:

Vinblastine has proved effective in the treatment of the following neoplasms, either alone or in conjunction with other oncolytic drugs:Frequently Responsive Malignancies :• Generalized Hodgkin's disease (Stages III and IV, Ann Arbor modification of Rye staging system)• Non-Hodgkin's lymphoma: - Reticulum-cell sarcoma - Lymphosarcoma• Mycosis fungoides.• Neuroblastoma.• Histiocytosis X.Less Frequently Responsive Malignancies :• Choriocarcinoma resistant to other chemotherapeutic agents.• Embryonal carcinoma of the testis.• Carcinoma of the breast, unresponsive to appropriate endocrine surgery and hormonal therapy.

Authorization date:

2016-08-31